How letting your mind wander can reset your brain
PTI
Preston, Aug 7 (The Conversation) Every day, we're faced with constant opportunities for stimulation. With 24/7 access to news feeds, emails and social media, many of us find ourselves scrolling endlessly, chasing our next hit of dopamine. But these habits are fuelling our stress – and our brains are begging for a break.
What our brains really need is some much needed time off from concentrating. By not consciously focusing on anything and allowing the mind to drift, this can reduce stress and improve cognitive sharpness.
This can often be easier said than done. But attention restoration theory (Art) can help you learn to give your brain space to drift. While this might sound like a fancy name for doing nothing, the theory is supported by neuroscience.
Attention restoration theory was first put forward by psychologists Rachel and Stephen Kaplan in 1989. They theorised that spending time in nature can help to restore focus and attention.
They proposed there are two distinct types of attention: directed attention and undirected attention. Directed attention refers to deliberate concentration – such as studying, navigating through a busy place or posting on social media. Basically, it's any activity where our brain's attention is being directed at a specific task.
Undirected attention is when we're not consciously trying to focus on anything – instead allowing things to gently capture our attention without trying. Think listening to chirping birds or watching leaves gently rustling in the breeze. In these instances, your attention naturally drifts without having to force your focus.
Without time for undirected attention, it's thought that we experience 'attentional fatigue". This can make it increasingly difficult to focus and concentrate, while distractions become more likely to grab our attention.
In the past, we encountered many situations in our daily lives that we might classify as 'boring". Moments such as waiting for the bus or standing in the supermarket queue. But these dull moments also gave our minds a chance to switch off.
Now, our smartphones give us the opportunity for constant entertainment. Being able to constantly expose ourselves to intense, gripping stimuli offers little mental space for our overworked brains to recover.
But attention restoration theory shows us how important it is to create space for moments that allow our brains to 'reset".
Restoring attention The origins of Kaplan and Kaplan's theory can actually be traced back to the 19th century. American psychologist William James was the first to formulate the concept of 'voluntary attention" – attention that requires effort. James' ideas were published against the backdrop of the broader cultural movement of Romanticism, which lauded nature.
Romantic ideas about the restorative power of nature have since been backed by research – with numerous studies showing links between time in nature and lower stress levels, better attention, improvements in mental health, mood and better cognitive function.
The restorative benefits of nature are backed by neuroscience, too. Neuroimaging has shown that activity in the amygdala – the part of the brain associated with stress and anxiety – was reduced when people were exposed to natural environments. But when exposed to urban environments, this activity was not reduced.
Numerous studies have also since backed up Kaplan and Kaplan's theory that time in nature can help to restore attention and wellbeing. One systematic review of 42 studies found an association with exposure to natural environments and improvements in several aspects of cognitive performance – including attention.
A randomised controlled trial using neuroimaging of the brain found signs of lower stress levels in adults who took a 40-minute walk in a natural environment, compared to participants who walked in an urban environment. The authors concluded that the nature walk facilitated attention restoration.
Research has even shown that as little as ten minutes of undirected attention can result in a measurable uptick in performance on cognitive tests, as well as a reduction in attentional fatigue. Even simply walking on a treadmill while looking at a nature scene can produce this cognitive effect.
Time in nature There are many ways you can put attention restoration theory to the test on your own. First, find any kind of green space – whether that's your local park, a river you can sit beside or a forest trail you can hike along. Next, make sure you put your phone and any other distractions away.
Or, when you face boring moments during your day, instead of picking up your phone try seeing the pause as an opportunity to let your mind wander for a bit.
Each of us may find certain environments to be more naturally supportive in allowing us to switch off and disengage the mind. So if while trying to put attention restoration theory into practice you find your brain pulling you back to structured tasks (such as mentally planning your week), this may be sign you should go someplace where it's easier for your mind to wander.
Whether you're watching a ladybird crawl across your desk or visiting a vast expanse of nature, allow your attention to be undirected. It's not laziness, it's neurological maintenance. (The Conversation) GSP
(This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments
First Published:
August 07, 2025, 14:45 IST
News agency-feeds How letting your mind wander can reset your brain
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
3 hours ago
- Economic Times
US honey bee deaths reach record high; Varroa mites threaten crops and drive up food prices
US honey bee colonies are facing unprecedented losses due to pesticide-resistant Varroa mites, leading to the spread of deadly viruses. This threatens American agriculture, potentially increasing food costs and reducing the availability of essential crops like almonds and apples. Researchers are urgently seeking solutions, including breeding mite-resistant bees, to mitigate the devastating impact on pollination and food security. Tired of too many ads? Remove Ads A parasite that bleeds bees dry Tired of too many ads? Remove Ads Impact on US agriculture Multiple threats, compounding losses US honey bee colonies are dying at record levels, and scientists say a tiny but devastating parasite is largely to blame. Varroa destructor mites have evolved resistance to a key pesticide, fueling the spread of deadly viruses and threatening a cornerstone of American pollinator populations crash, Americans could see higher grocery bills, fewer fresh produce options, and increased reliance on imported foods. Everyday staples like apples, almonds, blueberries, pumpkins, and melons could become more expensive and less US Department of Agriculture (USDA) reports that commercial beekeepers lost more than 60 percent of their colonies between summer 2024 and January 2025, the highest losses ever recorded since nationwide tracking began. That amounts to roughly 1.7 million colonies and an estimated $600 million in economic damage.'These losses are unprecedented,' said Danielle Downey, executive director of Project Apis m., a nonprofit focused on honey bee health. 'Without immediate intervention, we risk higher food costs, disrupted crop production, and the collapse of many commercial beekeeping operations.'Varroa mites, first detected in the US in the 1980s, feed on bees' body fat and blood while transmitting lethal viruses such as deformed wing virus A and B and acute bee paralysis. The USDA's Agricultural Research Service found evidence that mites collected from collapsed colonies across western states were resistant to amitraz, the primary chemical treatment used by US beekeepers for nearly two are critical to pollinating crops that make up about one-third of the American diet, including almonds, apples, blueberries, cucumbers, and melons. The USDA estimates bee-pollinated crops are worth over $20 billion annually in the US and $387 billion almond industry alone, which produces 80 percent of the world's almonds, relies on 1.7 million hives for pollination each spring. This year's bee shortage has already raised concerns about the upcoming pesticide-resistant mites are the prime suspect, experts stress that bee mortality is also driven by pesticides, poor nutrition, pathogens, and poor hive management. Some beekeepers say fungicides and neonicotinoid pesticides, banned in Europe but still used in the US, further weaken are racing to breed 'hygienic' bees capable of detecting and removing mites from their hives. Texas A&M University recently launched the state's first bee breeding center, aiming to produce mite-resistant queens for commercial now, many beekeepers are switching between different treatments to slow resistance and protect their remaining hives. But scientists warn the window for action is narrowing.
Time of India
5 hours ago
- Time of India
If you're eating like most Americans, you are already closer to death, CDC warns
Americans are increasingly relying on ultraprocessed foods (UPFs) for their daily meals, now tied to alarming health risks, according to new federal data and expert advisories. Ultraprocessed foods now account for more than half of the calories consumed in the United States, according to new data from the Centers for Disease Control and Prevention . The report based on dietary data from August 2021 to August 2023, reveals that over 55 percent of the average American's daily calories come from UPFs, which nearly 62 percent among children and teens. This marks a small but notable decline from previous years, with intake decreasing by about 3 percent among adults and 3.7 percent among youth compared to 2017–2018 Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program What are UPFs? by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Undo Ultraprocessed foods are industrially manufactured items that include additives, like emulsifiers, artificial dyes, and flavorings, and multiple ingredients seldom found in a home kitchen. They often deliver a potent mix of high sugar, salt, and unhealthy fats (HFSS), while stripping away natural fiber and nutrients. While some UPFs, like certain whole-grain breads or low-sugar yogurts, may offer modest nutritional value, most contribute little more than empty calories. Health risks Studies consistently show a dose-response relationship between UPF consumption and worsening health. High intake correlates with elevated risks of obesity, type 2 diabetes, heart disease, various cancers, and even early death. For every 10 percent increase in UPF calories, the risk of early mortality jumps nearly 3 percent, with researchers estimating 124,000 premature deaths in the US in 2018 alone were tied to UPF consumption, surpassing fatalities from fentanyl overdoses. Live Events Further reinforcing these findings, a recent clinical trial showed that participants who switched from UPFs to minimally processed meals lost twice as much weight, even when the calorie and nutrient content remained equal. How to stay safe? Public health officials are calling for bold action like clearer labeling, limits on marketing to children, and stronger regulation of food additives. Health Secretary Robert F. Kennedy Jr. has elevated UPFs as a national health priority, urging reform of the food environment.
&w=3840&q=100)
Business Standard
15 hours ago
- Business Standard
How Ozempic maker Novo Nordisk lost sheen after creating wonder drug
Eshe Nelson For years, there was no stopping Novo Nordisk, the Danish drugmaker behind Ozempic. Its diabetes drug became a cultural phenomenon for its ability to induce drastic weight loss while also reducing the risk of heart attacks and other serious diseases in people with obesity. Then, suddenly, its fortunes took a turn. Novo Nordisk's share price has plummeted more than 50 per cent this year, pushing it out of the top ten list of Europe's most valuable companies. The company bewildered analysts in May when it abruptly said it would replace its chief executive, and it has seemed unable to keep ahead of competition from the American drugmaker Eli Lilly and the prevalence of cheap copycat versions. 'The market's got no patience for Novo,' said Gareth Powell, the head of health care at Polar Capital, a fund manager. 'Sentiment is absolutely dire.' On Wednesday, Novo Nordisk reported $24 billion in global sales in the first six months of the year, but reiterated it expects growth to slow rest of the year, which it first flagged in a profit warning last week. Ozempic, which came onto the market in late 2017, led to substantial weight loss and quickly attracted cultural cachet, not least because of its use among celebrities. TikTok videos documenting people's journey with Ozempic attracted millions of views. In the first half of the year, Novo Nordisk made $10 billion in sales from Ozempic, of which 70 percent was in the United States. For a company that had been focused on the steady business of selling insulin, the popularity of Ozempic took its executives by surprise. In 2021, they started selling Wegovy, semaglutide marketed specifically for weight loss, but demand was so high that the company struggled to meet it. That shortage 'opened a whole can of worms,' said Rajesh Kumar, an analyst at HSBC. In 2022, semaglutide landed on the Food and Drug Administration's shortage list, which spurred production of cheaper copycat versions of Novo Nordisk's drugs. To ensure the supply of medicines facing shortages, US federal law allows companies to produce versions of patented drugs via a process of mixing ingredients called compounding. Novo Nordisk said last week that more than one million people were still using compounded GLP-1s, eating into the company's market share and forcing it to slash sales and profit forecasts. Novo Nordisk had a huge head start. After Ozempic went on sale, it was another four and a half years before a serious competitor emerged: Eli Lilly's Mounjaro, the brand name for tirzepatide, a drug used to treat diabetes. Novo Nordisk was further hampered by its slowness in introducing a direct-to-consumer sales platform. NovoCare Pharmacy launched in March, 14 months after LillyDirect. More than anything, a firm's market value is determined by investors' expectations for earnings in the future. For a pharmaceutical firm, that means the drugs in its pipeline. This has helped Eli Lilly's stock, which is roughly flat for the year, outperform Novo Nordisk's sinking share price. Eli Lilly's daily pill, orforglipron, has shown promising results in late-stage clinical trials, with similar weight loss to Novo Nordisk's injections and fewer restrictions on its use. Novo Nordisk's oral tablet leads to less weight loss than its injections, but the company has other pills in development. Concerns are mounting that analysts may have overestimated the potential size of the weight-loss market, or at least how easily more people will gain access to these drugs. At the same time, President Trump is pressuring companies to lower drug prices and threatening tariffs on medicines produced abroad, casting a cloud over pharma firms' business models. 'I still believe there's a big market,' said Mr. Powell of Polar Capital, which invests in both Novo Nordisk and Eli Lilly. But broad concerns about the market are hitting Novo Nordisk hardest, he added.
